SCHEMBL668355

SCHEMBL668355

CCCCN[C@@H](Cc1ccccc1)C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.58
FAAH O00519 2/20 0.54
MME P08473 3/20 0.51
ACE P12821 2/20 0.51
CPA1 P15085 2/20 0.51
ACE2 Q9BYF1 2/20 0.51
LMNA P02545 1/20 0.51
GGT1 P19440 1/20 0.50
POLB P06746 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
NPSR1 Q6W5P4 1/20 0.48
SIGMAR1 Q99720 1/20 0.47
HDAC3 O15379 2/20 0.47
HDAC4 P56524 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC2 Q92769 1/20 0.47
HDAC8 Q9BY41 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL668354 1.00 BCHE (0.58) BCHEFAAHMMEACECPA1
SCHEMBL249801 0.95 BCHE (0.54) BCHEFAAHMMEACECPA1
SCHEMBL249802 0.95 BCHE (0.54) BCHEFAAHMMEACECPA1
SCHEMBL3143813 0.95 BCHE (0.54) BCHEFAAHMMEACECPA1
Ethylenediamine SCHEMBL9008938 0.94 BCHE (0.54) BCHEFAAHMMEACECPA1
Ethylenediamine SCHEMBL9008941 0.94 BCHE (0.54) BCHEFAAHMMEACECPA1
SCHEMBL6702717 0.94 FAAH (0.55) BCHEFAAHMMEACECPA1
SCHEMBL6702715 0.94 FAAH (0.55) BCHEFAAHMMEACECPA1
SCHEMBL21585496 0.94 FAAH (0.55) BCHEFAAHMMEACECPA1
SCHEMBL3953856 0.94 FAAH (0.55) BCHEFAAHMMEACECPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023219933-A1 COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACID THERAPEUTICS ENTRADA THERAPEUTICS, INC. (US) 2023-11-16 WO claimed
EP-3291826-A1 ANTI-BACTERIAL AGENTS AND THEIR USE IN THERAPY Norwegian University of Science and Technology (NTNU) (NO) 2018-03-14 EP claimed
WO-2016177899-A9 ANTI-BACTERIAL AGENTS AND THEIR USE IN THERAPY NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY (NTNU) (NO) 2016-12-29 WO claimed
WO-2016177899-A1 ANTI-BACTERIAL AGENTS AND THEIR USE IN THERAPY NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY (NTNU) (NO) 2016-11-10 WO claimed
EP-3065759-A1 IMMUNOSUPPRESSIVE AGENTS AND THEIR USE IN THERAPY Norwegian University of Science and Technology (NTNU) (NO) 2016-09-14 EP claimed
CN-105143245-A Anti-scaling material YISSUM RES DEV CO 2015-12-09 CN claimed
WO-2015067712-A1 IMMUNOSUPPRESSIVE AGENTS AND THEIR USE IN THERAPY NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY (NTNU) (NO) 2015-05-14 WO claimed
JP-8103243-A None JP disclosed
EP-4720087-A1 PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR Zealand Pharma A/S (DK) 2026-04-08 EP disclosed
EP-4658667-A1 CYCLIC PEPTIDES FOR INHIBITING TNF RECEPTOR 1 ACTIVITY Merck Sharp & Dohme LLC (US) 2025-12-10 EP disclosed
CN-119547782-A Composition and application thereof in promoting grouting and ripening of rapeseeds 华南农业大学 2025-03-04 CN disclosed
WO-2024246269-A1 PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR ZEALAND PHARMA A/S (DK) 2024-12-05 WO disclosed
EP-4471048-A1 PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR Zealand Pharma A/S (DK) 2024-12-04 EP disclosed
EP-1263471-A2 ANTIMICROBIAL COMPOUNDS AND FORMULATIONS ALPHARMA AS (NO) 2002-12-11 EP disclosed
WO-2001066147-A2 ANTIMICROBIAL COMPOUNDS AND FORMULATIONS ALPHARMA AS (NO) 2001-09-13 WO disclosed
EP-0773956-A1 PURIFIED FORM OF STREPTOGRAMINES, PREPARATION OF SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME Aventis Pharma S.A. (FR) 1997-05-21 EP disclosed
US-5582814-A COMPLEX OF PARAMAGNETIC METAL AND 1-/PARA-BUTYLBENZYL/DIETHYLENETRIAMINEPENTAACETIC ACID METASYN, INC. (US) 1996-12-10 US disclosed
JP-H08103243-A SUSTAINABLE FLAVOR/SCENT IMPARTING AGENT T HASEGAWA CO LTD 1996-04-23 JP disclosed
WO-1996004298-A1 PURIFIED FORM OF STREPTOGRAMINES, PREPARATION OF SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME RHONE-POULENC RORER S.A. (FR) 1996-02-15 WO disclosed
WO-1995028179-A1 CONTRAST AGENTS FOR DIAGNOSTIC IMAGING METASYN, INC. (US) 1995-10-26 WO disclosed